Long-term efficacy and safety of alfuzosin 10 mg once daily: a 2-year experience in 'real-life' practice.
about
Silodosin for benign prostatic hyperplasia.Multicenter, prospective, comparative cohort study evaluating the efficacy and safety of alfuzosin 10 mg with regard to blood pressure in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia with or without antihypertensiCombination of phosphodiesterase-5 inhibitors and alpha-blockers in patients with benign prostatic hyperplasia: treatments of lower urinary tract symptoms, erectile dysfunction, or both?Medical therapy options for aging men with benign prostatic hyperplasia: focus on alfuzosin 10 mg once daily.Update on the sexual impact of treatment for benign prostatic hyperplasia.Etiology, evaluation, and management of nocturia in elderly men and women.Alfuzosin 10 mg once daily for treating benign prostatic hyperplasia: a 3-year experience in real-life practice.Randomized Controlled Trial to Assess the Efficacy of the Combination Therapy of Alfuzosin and Tadalafil in Patients with Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia.Improving BPH symptoms and sexual dysfunctions with a saw palmetto preparation? Results from a pilot trial.Physician perceptions of sexual dysfunction related to benign prostatic hyperplasia (BPH) symptoms and sexual side effects related to BPH medications.Cardiovascular/Pulmonary Medications and Male Reproduction.An animal model to study lower urinary tract symptoms and erectile dysfunction: the hyperlipidaemic rat.Alfuzosin 10 mg once daily prevents overall clinical progression of benign prostatic hyperplasia but not acute urinary retention: results of a 2-year placebo-controlled study.
P2860
Q33158241-4F318B1E-D559-4920-BFA4-AB06D54D62B7Q35001406-AF574C7F-94A5-4EC2-AB7A-F07C8A25319EQ36409148-6BDF4CCD-75F1-4C33-87AF-6FBD41A873BDQ37192948-D982519C-F59C-4589-BA53-BF09F82B8719Q38052091-2A55C5A1-0A76-426B-8085-645D3D5EB87BQ38200832-BE9C6D26-DBD1-4929-8591-2AD01C236768Q39322787-F6D97251-B41F-4431-A478-B6F6A787AC8CQ40215706-935CBF41-85B6-40F5-981B-53891C231C2EQ43673195-E81DAB77-77BA-469A-8E44-0BA981F4E115Q44982532-759850C4-C09D-46AA-A8D5-95787470FE22Q46236880-2788517E-FE46-4040-A808-D3589C9E429CQ46560411-C1D99E2A-CDE1-48A9-BA8A-15EA1A999E8BQ46990092-C869E529-4EC8-48A9-84DC-47A54E60E689
P2860
Long-term efficacy and safety of alfuzosin 10 mg once daily: a 2-year experience in 'real-life' practice.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Long-term efficacy and safety ...... ience in 'real-life' practice.
@en
Long-term efficacy and safety ...... ience in 'real-life' practice.
@nl
type
label
Long-term efficacy and safety ...... ience in 'real-life' practice.
@en
Long-term efficacy and safety ...... ience in 'real-life' practice.
@nl
prefLabel
Long-term efficacy and safety ...... ience in 'real-life' practice.
@en
Long-term efficacy and safety ...... ience in 'real-life' practice.
@nl
P2093
P2860
P1433
P1476
Long-term efficacy and safety ...... ience in 'real-life' practice.
@en
P2093
ALF-ONE Study Group
Antonio Alcaraz
Guy Vallancien
Haim Matzkin
Mostafa Elhilali
Niels Harving
R Jeroen A van Moorselaar
Rudolf Hartung
P2860
P304
P356
10.1111/J.1464-410X.2005.05962.X
P577
2006-03-01T00:00:00Z